针对PSMA的放射性光学的图书法测量和科学测量分析:知识映射和全球地位
Mohamed Sallam1,2,3, Mahan Mohammadi4, Frank Sainsbury2,3
1Queensland Micro- and Nanotechnology Centre (QMNC), Griffith University, Nathan, QLD, Australia.
Frontiers in oncology
|July 16, 2024
概括
这份图书统计分析对前列腺特异性膜抗原 (PSMA) 向放射性疗法进行了30年的研究,确定了关键趋势和贡献者. 它强调需要加强合作和基础设施,以推进基于PSMA的癌症诊断和治疗.
科学领域:
- 辐射治疗和核医学
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
背景情况:
- 圣经计量和科学计量分析为研究趋势和学术成果提供了结构化的洞察力.
- 没有以前的图书统计或科学测量研究集中在前列腺特异性膜抗原 (PSMA) 向的放射性射剂上.
- 了解研究环境对于指导该领域未来发展至关重要.
研究的目的:
- 进行对PSMA向的辐射度学研究进行全面的文献计和科学计分析.
- 确定全球关键贡献者,评估科学生产,并预测未来的研究模式.
- 绘制研究主题的演变图,并确定PSMA领域有影响力的实体.
主要方法:
- 利用科学计量和文献计量来分析PSMA向辐射度学知识的演变.
- 采用科学绘图技术来可视化研究活动.
- 在Web of Science (WoS) 数据库中进行了搜索,使用VOSviewer分析了1993年1月至2023年1月的694项英语研究.
主要成果:
- 分析涵盖了30年 (1993-2023) 的694项原始研究.
- 通过图书计量和科学计量方法,绘制了出版趋势,领先的国家,共同引用和共同作者网络.
- 确定了PSMA研究中的进化模式,新兴趋势,异常值和关键参与者,提供了对该领域的细微了解.
结论:
- 这项研究通过详细的全球分析,丰富了对PSMA向辐射射的知识.
- 强调需要改进沟通平台,支持基础设施和主动解决方案.
- 为推进基于PSMA的前列腺癌诊断和治疗提供战略资源,敦促继续取得进展.
更多相关视频
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.3K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.8K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
